Author： McKeage K. Scott L.J.
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.17, Iss.9, 2003-01, pp. : 669-675
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
SLI-381 (Adderall XR®): A Viewpoint by Charlotte Johnston
By Johnston C.
CNS Drugs, Vol. 17, Iss. 9, 2003-01 ,pp. :
Access to resources
Recommend
Revised labelling for Adderall XR in Canada
Reactions Weekly, Vol. 1, Iss. 1068, 2005-01 ,pp. :
Adderall XR Restored to Canadian Market
Child and Adolescent Psychopharmacology News, Vol. 10, Iss. 4, 2005-06 ,pp. :
Adderall XR allowed back on the Canadian market
Reactions Weekly, Vol. 1, Iss. 1067, 2005-01 ,pp. :
Atomoxetine/SLI 381: Hallucinations, paranoid disorders and mania in children: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. :